Drug abuse treatment entry and engagement: Report of a meeting on treatment readiness
β Scribed by Robert J. Battjes; Lisa S. Onken; Peter J. Delany
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 91 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0021-9762
No coin nor oath required. For personal study only.
β¦ Synopsis
Although the effectiveness of drug abuse treatment has been demonstrated repeatedly, many drug abusers do not enter treatment, many who do enter leave prematurely, and relapse following treatment is common. To further research treatment entry and engagement, the National Institute on Drug Abuse convened scientists representing diverse research traditions in December 1996. This article summarizes meeting presentations and recommendations. Presentations focused on treatment readiness/ motivation for change, ethnographic reports of drug abusers' perceptions of and attitudes toward treatment, and reports on alternative treatments for high-risk drug abusers. Recommendations focused on the potential contribution of qualitative research, integration of qualitative and quantitative research approaches, development of flexible treatment approaches that are cognizant of patients' life circumstances, and services research to improve the organization and delivery of drug abuse treatment.
π SIMILAR VOLUMES
## Abstract This paper presents results from the first largeβscale outcome study of American Family Treatment Drug Courts (FTDCs)βspecialised courts designed to work with substanceβabusing parents involved with the child welfare system. The paper examines whether court, child welfare and treatment
Background. There has been widespread development of clinical guidelines for the treatment of Alzheimer's disease since the introduction of donepezil in the UK in 1997. These have been developed nationally, regionally, locally and by independent groups. An independent review of guidelines available
To the Editor: A 42-year-old Chinese woman suffered from acute lymphoblastic leukemia (ALL) with t(9;22) and achieved complete remission with induction chemotherapy without imatinib mesylate (STI-571). She had one 40-year-old HLA identical sister from Fujian province, China. However, repeated human
Background: Percutaneous aortic valve replacement is a new technology for the treatment of patients with significant aortic valve stenosis. We present the first report on a human implantation of a self-expanding aortic valve prosthesis, which is composed of three bovine pericardial leaflets inserted